Research & Analytics WNS Signs Contract Extension for Pharmaceutical Research & Analytics Services

Editor: Dominik Stephan

WNS (Holdings), a leading provider of global Business Process Outsourcing (BPO) services, announced today that it has extended its contract with global pharmaceutical leader Glaxo Smith Kline Services Unlimited (GSK), to deliver high-end research and analytics services.

Related Companies

(Process: PROCESS)

Mumbai/India – "In a rapidly changing and increasingly competitive global economy, the ability to analyze large amounts of complex data to drive insight-based decisions is critical to success. WNS has been a trusted partner in delivering these high-value analytics solutions to GSK, and we are delighted to announce this contract extension with a recognized leader in the pharmaceutical industry,” said Keshav R. Murugesh, Group CEO, WNS Global Services.

WNS enables its global clients to make critical business decisions leveraging its research and analytics expertise, deep industry knowledge and robust delivery capabilities. WNS currently has over 2,000 research and analytics professionals supporting areas such as customer lifecycle analytics, market and business research, strategy and decision support, demand forecasting, customer risk scoring, loss management modeling, and measurement and reporting.